Back to today’s briefing

Story perspectives

Revolutionary Drug Offers Hope for Leigh Syndrome Patients

2/23/2025

48 3

Summary

Story summary

A groundbreaking drug, HypoxyStat, developed by researchers at the Gladstone Institutes and UCSF, mimics the effects of low-oxygen mountain air, offering hope for Leigh syndrome patients. In mice, it not only reversed brain damage but also significantly extended lifespans. The team is now focused on creating a second-generation version for human trials, aiming to transform treatment for mitochondrial diseases.

1 of 1

Story summary

A groundbreaking drug, HypoxyStat, developed by researchers at the Gladstone Institutes and UCSF, mimics the effects of low-oxygen mountain air, offering hope for Leigh syndrome patients. In mice, it not only reversed brain damage but also significantly extended lifespans. The team is now focused on creating a second-generation version for human trials, aiming to transform treatment for mitochondrial diseases.